O-1 PanCO: Updated results of an open-label, single-arm pilot study of OncoSil P-32 microparticles in unresectable locally advanced pancreatic adenocarcinoma (LAPC) with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2020 Published by Elsevier Ltd.